Commercial tobacco and indigenous peoples: a stock take on Framework Convention on Tobacco Control progress.


Journal

Tobacco control
ISSN: 1468-3318
Titre abrégé: Tob Control
Pays: England
ID NLM: 9209612

Informations de publication

Date de publication:
09 2019
Historique:
received: 02 06 2018
revised: 17 07 2018
accepted: 18 07 2018
pubmed: 5 8 2018
medline: 10 9 2020
entrez: 5 8 2018
Statut: ppublish

Résumé

The health status and needs of indigenous populations of Australia, Canada and New Zealand are often compared because of the shared experience of colonisation. One enduring impact has been a disproportionately high rate of commercial tobacco use compared with non-indigenous populations. All three countries have ratified the WHO Framework Convention on Tobacco Control (FCTC), which acknowledges the harm caused to indigenous peoples by tobacco. We evaluated and compared reporting on FCTC progress related to indigenous peoples by Australia, Canada and New Zealand as States Parties. The critiqued data included disparities in smoking prevalence between indigenous and non-indigenous peoples; extent of indigenous participation in tobacco control development, implementation and evaluation; and what indigenous commercial tobacco reduction interventions were delivered and evaluated. We searched FCTC: (1) Global Progress Reports for information regarding indigenous peoples in Australia, Canada and New Zealand; and (2) country-specific reports from Australia, Canada and New Zealand between 2007 and 2016. Two of the authors independently reviewed the FCTC Global and respective Country Reports, identifying where indigenous search terms appeared. All data associated with the identified search terms were extracted, and content analysis was applied. It is difficult to determine if or what progress has been made to reduce commercial tobacco use by the three States Parties as part of their commitments under FCTC reporting systems. There is some evidence that progress is being made towards reducing indigenous commercial tobacco use, including the implementation of indigenous-focused initiatives. However, there are significant gaps and inconsistencies in reporting. Strengthening FCTC reporting instruments to include standardised indigenous-specific data will help to realise the FCTC Guiding Principles by holding States Parties to account and building momentum for reducing the high prevalence of commercial tobacco use among indigenous peoples.

Sections du résumé

BACKGROUND
The health status and needs of indigenous populations of Australia, Canada and New Zealand are often compared because of the shared experience of colonisation. One enduring impact has been a disproportionately high rate of commercial tobacco use compared with non-indigenous populations. All three countries have ratified the WHO Framework Convention on Tobacco Control (FCTC), which acknowledges the harm caused to indigenous peoples by tobacco.
AIM AND OBJECTIVES
We evaluated and compared reporting on FCTC progress related to indigenous peoples by Australia, Canada and New Zealand as States Parties. The critiqued data included disparities in smoking prevalence between indigenous and non-indigenous peoples; extent of indigenous participation in tobacco control development, implementation and evaluation; and what indigenous commercial tobacco reduction interventions were delivered and evaluated.
DATA SOURCES
We searched FCTC: (1) Global Progress Reports for information regarding indigenous peoples in Australia, Canada and New Zealand; and (2) country-specific reports from Australia, Canada and New Zealand between 2007 and 2016.
STUDY SELECTION
Two of the authors independently reviewed the FCTC Global and respective Country Reports, identifying where indigenous search terms appeared.
DATA EXTRACTION
All data associated with the identified search terms were extracted, and content analysis was applied.
RESULTS
It is difficult to determine if or what progress has been made to reduce commercial tobacco use by the three States Parties as part of their commitments under FCTC reporting systems. There is some evidence that progress is being made towards reducing indigenous commercial tobacco use, including the implementation of indigenous-focused initiatives. However, there are significant gaps and inconsistencies in reporting. Strengthening FCTC reporting instruments to include standardised indigenous-specific data will help to realise the FCTC Guiding Principles by holding States Parties to account and building momentum for reducing the high prevalence of commercial tobacco use among indigenous peoples.

Identifiants

pubmed: 30076238
pii: tobaccocontrol-2018-054508
doi: 10.1136/tobaccocontrol-2018-054508
pmc: PMC6824741
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

574-581

Subventions

Organisme : NCI NIH HHS
ID : R01 CA091021
Pays : United States
Organisme : CIHR
ID : 379337
Pays : Canada

Informations de copyright

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Lancet. 2006 Jul 1;368(9529):44-52
pubmed: 16815379
CMAJ. 2006 Sep 12;175(6):602
pubmed: 16966664
Med J Aust. 2015 Jun 1;202(10):S3-4
pubmed: 26017253
Qual Health Res. 2005 Nov;15(9):1277-88
pubmed: 16204405
Aust N Z J Public Health. 2008 Apr;32(2):110-6
pubmed: 18412679
Ann N Y Acad Sci. 1999;896:173-88
pubmed: 10681897
Lancet. 2007 Nov 24;370(9601):1756
pubmed: 18037079
Syst Rev. 2017 Jul 10;6(1):135
pubmed: 28693556
Stat J IAOS. 2015;31(1):67-87
pubmed: 26793283
Public Health Res Pract. 2017 Oct 11;27(4):null
pubmed: 29114713
BMC Public Health. 2016 Jan 11;16:21
pubmed: 26754922

Auteurs

Raglan Maddox (R)

Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, Well Living House, St. Michael's Hospital, Toronto, Ontario, Canada.
Centre for Research and Action in Public Health, University of Canberra, Canberra, Australian Capital Territory, Australia.

Andrew Waa (A)

Eru Pomare Māori Health Research Unit, University of Otago, Wellington, New Zealand.

Kelley Lee (K)

Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada.

Patricia Nez Henderson (P)

Black Hills Center for American Indian Health, Rapid City, South Dakota, USA.

Genevieve Blais (G)

Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, Well Living House, St. Michael's Hospital, Toronto, Ontario, Canada.

Jeff Reading (J)

British Columbia First Nations Health Authority Chair in Heart Health and Wellness, I-HEART Centre St. Paul's Hospital, Providence Health Care, West Vancouver, British Columbia, Canada.

Raymond Lovett (R)

National Centre for Epidemiology and Population Health, Research School of Population Health, ANU College of Medicine, Biology and Environment, Canberra, Australian Capital Territory, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH